سعر ايميجران 100مجم 6 قرص 2026

Imigran (sumatriptan) 100 mg oral tablets, pack of 6; a selective 5-HT1B/1D receptor agonist (triptan) for acute migraine attacks.

• Acute treatment of migraine with or without aura in adults (not for prevention of migraine attacks or for cluster headache)Population: AdultsDailyMed (U.S. National Library of Medicine)

• Most common (>=2% and more than placebo): paresthesia, warm/cold sensation, chest pain/tightness/pressure or heaviness, neck/throat/jaw pain or pressure, other pain/pressure sensations, vertigo and malaise/fatigue.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Ischemic coronary artery disease (angina, prior myocardial infarction, silent ischemia) or coronary vasospasm including Prinzmetal’s angina.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Wolff-Parkinson-White syndrome or arrhythmias with other accessory conduction pathway disorders.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• History of stroke, transient ischemic attack, or hemiplegic or basilar migraine; peripheral vascular disease; ischemic bowel disease; uncontrolled hypertension.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Myocardial ischemia/infarction and Prinzmetal’s angina have been reported; perform cardiovascular evaluation in triptan-naive patients with multiple cardiovascular risk factors.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Arrhythmias, cerebrovascular events (cerebral/subarachnoid hemorrhage, stroke), gastrointestinal ischemia and peripheral vasospastic reactions: discontinue if they occur.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Chest, throat, neck or jaw pain/tightness/pressure is usually non-cardiac but warrants evaluation in high-risk patients; medication overuse headache may occur; serotonin syndrome; seizures (caution in epilepsy); blood pressure increases.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Ergot-containing drugs (ergotamine, dihydroergotamine, methysergide)Additive prolonged vasospastic reactions; use within 24 hours of each other is contraindicated.DailyMed (U.S. National Library of Medicine)
• MAO-A inhibitorsIncrease sumatriptan systemic exposure 7-fold; contraindicated (including within 2 weeks of stopping).DailyMed (U.S. National Library of Medicine)
• Other 5-HT1 agonists (triptans)Additive vasospastic effects; coadministration within 24 hours is contraindicated.DailyMed (U.S. National Library of Medicine)

• Pregnancy registry and epidemiological data have not detected an increased frequency or consistent pattern of birth defects with sumatriptan; animal studies showed embryolethality, fetal abnormalities and pup mortality.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Sumatriptan is excreted in human milk after subcutaneous use; no data after tablets or on effects in the breastfed infant; weigh benefits of breastfeeding against maternal need.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Sumatriptan: Agonist at 5-HT1B/1D receptors on intracranial blood vessels and trigeminal sensory nerves, causing cranial vessel constriction and inhibiting pro-inflammatory neuropeptide release.